Newsletter | November 2, 2022

11.02.22 -- Accelerating Clinical Development For U.S. Biotechs In The Asia Pacific

Clinical Development Strategies For Western Biotech Companies In China

Delve into how China is now more aligned with international standards, enabling biotech firms to streamline processes and timelines, which has significantly recharged biotech innovation.

Evolution Of Clinical Trials In The Asia Pacific Region

During the analysis period between 2017-2021, over 70,000 new clinical trials were registered in the APAC region, the U.S., and the EU. With this changing landscape, explore how APAC is emerging as the new hot spot for conducting clinical trials, especially in China.

The Biotech Landscape: Market Trends, Priorities, Predictions, And Pathways To FDA Approval

The webinar features regulatory affairs and investment leaders from North America and Asia Pacific who will discuss why biotech companies are increasingly exploring clinical opportunities in Asia Pacific to generate diverse, globally accepted clinical trial data, and much more.

The Immuno-Oncology Clinical Trial Landscape In The Asia Pacific

Learn how the Asia Pacific has shown significant increase in Immuno-oncology (IO) trials between 2017 and 2021 and contributes to about 35% of clinical development in IO globally. 

Accelerate Your Clinical Development Program With Novotech

Novotech is internationally recognized as the leading Asia Pacific centred Global Biotech clinical research organization (CRO). Talk to an expert at Novotech on taking advantage of the world’s fastest-growing clinical trials region today.

Request Information